HOME / Notice / News / EN
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=008&aid=0004587200 NKCL Bio Group (NKCL hereafter) revealed that it will be providing a service for checking body immunity and analyzing 5 immunity indicators, as a part of their representative technology, microbiome t...
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=001&oid=016&aid=0001824826 NKCL launches ‘NK Immune Biome Core 1,2,3’, the human microbiome restoration program. NKCL had launched the product, ‘NK Immune Biome Core 1,2,3’ which recovers the balance of gut bacteria in ord...
https://news.mt.co.kr/mtview.php?no=2021033114321879523 According to the research, ‘Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022’, conducted by global market research firm, Frost & Sullivan, the market size will grow by 13.7% annually for ...
https://n.news.naver.com/article/215/0000940774 NKCL Bio Group has opened 15-weeks course on nutritional health and functional medicine in Yonsei University, for upcoming semester on this March. Previously, last October, NKCL opened a university course on immunity at Songwon University. This is the s...
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=014&aid=0004570475 [The Establishment Ceremony] On January 22nd, NKCL Bio Group Inc. has commenced Microbiome R&D Center, which will mark a new chapter of immunity and functional medicine. Due to COVID-19, the esta...